How a Sudden-Onset Change in a Child Gets Evaluated

Your child went to bed one person and woke up another. The handwriting changed. The eating changed. There is rage where there was no rage, and a fear of something that was fine last Tuesday.

You are not describing a phase. You are describing a date. Here is how I work that up.

What do parents ask me most about this?

Short answers first. The full reasoning is below.

My child changed almost overnight. What does an evaluation actually look at?

A sudden-onset evaluation looks at three things at once: the timeline, the immune picture, and the nervous system.

What is the Neural Zoomer, and what does it show?

The Neural Zoomer is a blood panel that looks for antibodies against proteins in the nervous system, along with markers for several infections tied to sudden neuropsychiatric change.

Why do you check strep, mycoplasma and EBV markers?

I check strep, mycoplasma and EBV markers because these three infections keep showing up in the children I see whose behavior changed suddenly, and each one leaves a different footprint.

What does an EBV result actually mean?

An EBV result means more than positive or negative. Three antibodies read together separate a first infection from an old one from a reactivation.

Does a positive strep marker prove strep caused this?

No. A positive strep marker does not prove strep caused the change. In a meta-analysis of 29 studies, 12% of well children with no sore throat and no symptoms at all were carrying group…

What is it worth when a panel rules things out?

Ruling things out is half of what the panel buys you, and it is the half nobody talks about.

Which part of the workup answers which question?

Each part of a sudden-onset workup answers one question and only one. The Neural Zoomer looks at the nervous system and the immune activity around it.

What happens after the results come back?

After the results come back, my job is to set an order, not to start everything at once.

My child changed almost overnight. What does an evaluation actually look at?

A sudden-onset evaluation looks at three things at once: the timeline, the immune picture, and the nervous system. I order a Neural Zoomer panel along with strep, mycoplasma and EBV markers. Those labs do not make a diagnosis. They tell me what your child's immune system has been dealing with, and how long.

The timeline is the part I cannot order from a lab. Abrupt onset was the defining feature in the first 50 children ever described with this pattern. Their symptoms and tics arrived suddenly. Then they came and went in episodes.1 The 2013 PANS Consensus Conference built its recommended workup around that same idea. Its stated purpose is to look for infections and to look for other conditions that could explain the change, not to find one number that names the problem.2

So when I ask you for the date, and what happened the two weeks before the date, I am not making small talk. That history is the most powerful piece of data in the whole evaluation, and you are the only person who has it.

What is the Neural Zoomer, and what does it show?

The Neural Zoomer is a blood panel that looks for antibodies against proteins in the nervous system, along with markers for several infections tied to sudden neuropsychiatric change. It gives me a wide view from one draw. The Neural Zoomer is not a diagnostic test for PANS or PANDAS, and no lab result makes that diagnosis on its own.

What it gives me is a shape. Writing to one family about their son's results, I described "active Epstein-Barr Virus (EBV) reactivation, along with evidence of prior Streptococcus involvement and ongoing neuroimmune activation." That sentence told me what his immune system had been carrying, and roughly in what order. It did not tell me what to do. It told me what to look at next.

Antibody panels need to be read with a clinician, not read alone at midnight. In one study of children with basal ganglia encephalitis, antibodies to a specific dopamine receptor showed up in 12 of 17 affected children and in 0 of 67 healthy controls, which sounds decisive.3 In the same study those antibodies showed up in 10 of 30 children with Sydenham chorea and in 0 of 22 children with PANDAS.3 Present does not mean guilty. Absent does not mean fine.

Why do you check strep, mycoplasma and EBV markers?

I check strep, mycoplasma and EBV markers because these three infections keep showing up in the children I see whose behavior changed suddenly, and each one leaves a different footprint. Strep markers show whether there was past or recent involvement. Mycoplasma markers show whether that organism has been in the picture. EBV markers separate an old infection from an active reactivation.

Mycoplasma is worth explaining, because it behaves in two different ways. Researchers reviewed 365 children who had mycoplasma confirmed by PCR over a 16-year period. Forty-two of them, or 11.5%, had neurologic illness attributable to it, and encephalitis was the most common form at 52%.4 They found two distinct patterns. In some children the organism turned up in spinal fluid. In others it did not. That points to direct infection in the first group and an immune-driven process in the second.4

That distinction matters to me because the two patterns do not call for the same thinking. It is also a good illustration of why I do not stop at a single positive result.

What does an EBV result actually mean?

An EBV result means more than positive or negative. Three antibodies read together separate a first infection from an old one from a reactivation. Viral capsid antigen IgG plus EBNA-1 IgG, with no IgM, is the classic pattern of past infection. All three showing at once can mean recent infection or reactivation, and that pattern needs extra testing to sort out.5

Here is why the distinction is the whole point. In a national US survey, EBV antibody was already present in 50% of children aged 6 to 8, 55% of those aged 9 to 11, 59% of those aged 12 to 14, and 89% of 18 to 19 year olds.6 Half of second graders have already met this virus. So "positive for EBV" on its own tells me almost nothing about your child.

Reactivation is a different statement. It says the virus that has been quietly living in your child's body is active again, and the immune system is spending energy on it right now.

Does a positive strep marker prove strep caused this?

No. A positive strep marker does not prove strep caused the change. In a meta-analysis of 29 studies, 12% of well children with no sore throat and no symptoms at all were carrying group A strep in the throat, and among children who did have a sore throat, 37% grew it.7 Carrying strep is common. Changing overnight is not.

This is where the timeline does more work than the titer. A marker showing prior strep, next to a history where everything changed 10 days after a sore throat, means something. The same marker with no story around it does not.

I want to be direct with you about the limit here, because you have probably been told otherwise by someone. There is no lab test that proves an infection caused a child's neuropsychiatric change. Anyone who tells you their panel does that is selling certainty that does not exist.

Book My Free 15-Minute Call Free. No obligation. Not a sales call.

What is it worth when a panel rules things out?

Ruling things out is half of what the panel buys you, and it is the half nobody talks about. When I can tell a family the results show no sign of severe brain autoimmunity, no significant blood-brain barrier injury and no widespread neurologic damage, that changes things. It changes what I worry about tonight. It changes what I do next.

The exact sentence I wrote to one family was this: "we also confirmed that there isn't evidence of severe brain autoimmunity, significant blood-brain barrier injury, or widespread neurologic damage." That family had been living with a fear nobody had ever named out loud. Being able to close that door was worth as much to them as anything the panel found.

A reassuring panel is not a promise, and I will not present it as one. It does not replace neurology evaluation, imaging, an EEG or spinal fluid testing when the clinical picture calls for those. The international expert criteria for autoimmune encephalitis were written so that diagnosis rests on neurological assessment and standard testing. They deliberately do not wait on antibody results, because waiting delays care.8 That is the consensus, and I work alongside it rather than around it.

For anything to do with seizures, go straight to your child's neurology team. For a child who is not safe, not drinking, or talking about hurting themselves, go to emergency services. Those are not messages to send me and wait.

Which part of the workup answers which question?

Each part of a sudden-onset workup answers one question and only one. The Neural Zoomer looks at the nervous system and the immune activity around it. The infection markers look at what your child's body has met. The timeline you keep looks at cause and sequence. No single one of them replaces the other two.

Neural Zoomer

The question it answers: Whether there are antibodies against nervous system proteins, and whether there are signs of neuroimmune activation, blood-brain barrier injury or widespread neurologic damage

What it cannot answer: Whether your child has PANS or PANDAS. That is a clinical judgment built from history and exam, not a lab value

Strep markers

The question it answers: Whether there is evidence of past or recent strep involvement

What it cannot answer: Whether strep caused the change. About 12% of well children carry it in the throat with no symptoms at all

Mycoplasma markers

The question it answers: Whether mycoplasma has been part of the picture at all

What it cannot answer: Which of the two patterns you are looking at, direct or immune-driven. Those need the clinical story to separate

EBV markers

The question it answers: Whether this is a first infection, an old infection, or a reactivation happening now

What it cannot answer: Whether EBV is behind today's symptoms. Half of children aged 6 to 8 already carry EBV antibodies

The timeline you keep

The question it answers: When it started, what came in the two weeks before, and whether the pattern comes and goes

What it cannot answer: Nothing a lab can substitute for. This is the piece I cannot order

What happens after the results come back?

After the results come back, my job is to set an order, not to start everything at once. I look at what the labs show, then I look at your child's stools, sleep, movement and food, because those are the foundation everything else sits on. We are not trying to do everything at once.

The one rule I keep coming back to is order. If we push the clean-up work first, he can feel worse instead of better. So the plan moves one new thing at a time, several days apart, because if we start everything at once and he improves, or reacts, we will not know which piece did it.

Gut testing often runs alongside this, because gut and immune questions travel together in these children. That is what pediatric gut and microbiome testing is for. If you want the whole method rather than just the workup, what a natural pediatrician does walks through how I sequence it. And PANS and PANDAS care lays out what working with me on this actually looks like.

What can this evaluation not tell you?

This evaluation cannot tell you why it happened to your child and not the one down the street. It cannot promise you a timeline. And it cannot hand you a single number that makes the last six months make sense, because that number does not exist for this pattern in any lab in the country.

What it can do is replace guessing with a real map. It tells me what has been active, what has passed, what is quiet, and what I do not need to fear. That is not everything. It is a great deal more than you have right now.

You did not cause this. You noticed a date on a calendar when other people saw a mood, and you kept asking after you were told to stop. Your child needs exactly that person, and he already has her.

Book My Free 15-Minute Call Free. No obligation. Not a sales call.

Written by Dr. Amy Patton, Founder Happy Kid Functional Medicine

Book My Free 15-Minute Call

Get Clarity and Learn More.

About the author

This article was written by Dr. Amy Patton, DNP, APRN, CPNP-PC, FMACP, a board-certified pediatric nurse practitioner and functional medicine provider serving Omaha-area families through Happy Kid Functional Medicine. Dr. Patton specializes in root-cause pediatric care for children's gut health, sleep, behavior, nutrition, immune patterns, and whole-child wellness. She sees patients in person in Omaha and by telehealth across Arizona, Colorado, Iowa, Nebraska, Tennessee, and Virginia.

References

1. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. American Journal of Psychiatry. 1998;155(2):264–271. PubMed

2. Chang K, Frankovich J, Cooperstock M, Cunningham MW, Latimer ME, Murphy TK, Pasternack M, Thienemann M, Williams K, Walter J, Swedo SE. Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference. Journal of Child and Adolescent Psychopharmacology. 2015;25(1):3–13. PubMed

3. Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, Ben-Pazi H, Varadkar S, Aumann TD, Horne MK, Church AJ, Fath T, Brilot F. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012;135(Pt 11):3453–3468. PubMed

4. Al-Zaidy SA, MacGregor D, Mahant S, Richardson SE, Bitnun A. Neurological complications of PCR-proven M. pneumoniae infections in children: prodromal illness duration may reflect pathogenetic mechanism. Clinical Infectious Diseases. 2015;61(7):1092–1098. PubMed

5. De Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World Journal of Virology. 2012;1(1):31–43. PubMed

6. Balfour HH Jr, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6–19 years in the United States and factors affecting its acquisition. Journal of Infectious Diseases. 2013;208(8):1286–1293. PubMed

7. Shaikh N, Leonard E, Martin JM. Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics. 2010;126(3):e557–e564. PubMed

8. Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurology. 2016;15(4):391–404. PubMed

Medical disclaimer: This article is educational and is not medical advice. It does not diagnose, treat, or replace individualized care from your child's pediatrician or licensed medical provider. Supplement types, doses, and combinations should be selected with a qualified clinician who knows your child's full history — never start a new supplement based on a blog post alone. Always consult your pediatrician before making changes to your child's routine, and seek prompt medical care for snoring with gasping or pauses in breathing during sleep, or for any severe, sudden, or concerning symptom.